fbpx
Thursday, December 5, 2019
Home company Pacific Biosciences rises on $1.2 billion takeover deal from DNA sequencing business...
Pacific Biosciences rises on $1.2 billion takeover deal from DNA sequencing business Illumina (ILMN, PACB)

Pacific Biosciences rises on $1.2 billion takeover deal from DNA sequencing business Illumina (ILMN, PACB)

88
0

Illumina $1.2 billion acquisition of Pacific Biosciences – Organisation Expert.<br />
























  • DNA sequencing business Illumina revealed in a news release that it was getting Pacific Biosciences for roughly $1.2 billion. Illumina anticipates to close the deal in mid-2019
  • Illumina provided $8 a share for Pacific Biosciences. Pacific Biosciences shares leapt 67% in late trading to $7.51
  • Pacific Biosciences is a business that likewise concentrates on gene sequencing. Pacific Biosciences CEO Michael Hunkapiller stated in journalism release that the 2 business have complementary innovation abilities for examining genes, and when integrated, will open “brand-new frontiers of genomic energy.”
More:

Health
Health Care
Illumina
ILMN